Admission Date:  [**2113-11-5**]       Discharge Date:  [**2113-11-14**]


Service:  Acove
HISTORY OF PRESENT ILLNESS:  The patient has been steadily
improving since admission.  He is now on day #9 of 10 of the
Ceftriaxone for his positive BAL for Serratia and his
secretions have greatly decreased and the patient's oxygen
requirement has also greatly decreased.  The patient may be
fibrillation the patient continues to be on Coumadin, now at
10 mg q.d. to increase his INR above 2.0.  The patient's
hematocrit and hemoglobin has been stable throughout the
admission.  For aspiration, the patient has had a swallow
study on [**2113-11-10**] which he did not pass due to
silent aspirations.  The patient will need a follow up video
swallow study on [**2113-11-17**] and he will also need
Swallow study showed that the patient penetrated into the
laryngeal vestibule while swallowing which ultimately results
in aspiration and the patient does not cough spontaneously,
although is able to clear on que.

The patient's latest laboratory data were white count 6.6 on
[**2113-11-13**], hematocrit 31.9, INR 2.0, sodium 136,
potassium 4.1, magnesium 2.0.  The patient also had an
echocardiogram on [**2113-11-10**] which revealed a
moderately dilated left atrium, moderately dilated right
atrium and normal left ventricular function with an left
ventricular ejection fraction of 50 to 55%, normal right
ventricle, aortic valve leaflets, mildly thickened, no aortic
regurgitation, a bioprosthetic mitral valve with no mitral
regurgitation and tricuspid valve leaflets mildly thickened,
valve annuloplasty ring present, moderate 2+ tricuspid
regurgitation.  The patient was discharged in good condition
this morning on [**2113-11-14**].


Note: patient has mosaic bioprosthetic MVR which does not
require longterm anticoagulation.


DISCHARGE MEDICATIONS:
1.  Captopril 6.25 mg t.i.d.
2.  The patient is no longer on Zyprexa
3.  Metoprolol 25 mg b.i.d.
4.  Digoxin 0.125 mg q.d.
5.  Prozac 40 mg q.d.
6.  Ativan 0.5 mg q.h.s. prn
7.  Colace 100 mg b.i.d.
8.  Senna 1 tablet b.i.d.
9.  Simethicone 80 mg q.i.d.
10. Salmeterol 1 puff b.i.d.
11. Fluticasone 220 mcg 2 puffs b.i.d.
12. Ocean nasal spray, one to two sprays, NU q.i.d.
13. Nystatin oral suspension 5 mg q.i.d. prn
14. Albuterol nebulizers q. 4 hours prn
15. Ipratropium nebulizers q. 4 hours prn
16. Prevacid 30 mg q.d. via gastrostomy tube
17. Guaifenesin 5 to 10 ml q. 6 hours prn
18. Ceftriaxone 1 gm intravenously q.d., day #9 of 10,
treatment to end on [**2113-11-15**]
19. Lasix 20 mg q.d.
20. For tube feeds, Promote with fiber at 50 cc/hr and 250 cc
flushes of free water q. 4 hours
21. The patient was tried on CPAP at night, however, did not
tolerate it.




                            [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **], M.D.  [**MD Number(1) 2506**]

Dictated By:[**Last Name (NamePattern1) 4525**]
MEDQUIST36

D:  [**2113-11-14**]  09:19
T:  [**2113-11-14**]  09:26
JOB#:  [**Job Number 19398**]



